The IPO market is more than a parade of first-day price moves: it is a real-time read on investor risk appetite, liquidity, and the health of the private-company pipeline. After a quieter stretch, public markets have begun re-engaging with listings across software, fintech, and internet infrastructure. That renewed activity gives investors a fresh group of companies to evaluate, while public-market pricing can reset expectations for late-stage private peers. The central question for August 2026 is whether IPO momentum can become durable revenue growth, improving margins, and reliable access to follow-on capital.
The opportunity spans several layers of the IPO value chain. Investors can own the issuers themselves, platforms that help businesses operate after listing, and financial or technology infrastructure that benefits from greater issuance and trading activity. Software companies such as ServiceTitan, which completed its IPO in December 2024, show how vertical applications can reach public markets. Navan, Netskope, and Circle added more recent examples in travel software, cybersecurity, and digital-asset infrastructure, while Robinhood remains closely tied to retail participation and transaction activity.
This seven-stock countdown moves from #7 to #1. The ordering first emphasizes the depth of each company’s exposure to the IPO theme, then weighs business fundamentals such as growth, profitability, valuation, and earnings execution. That approach creates room for both direct IPO issuers and established public companies that can benefit from renewed market participation. The result is a mix of early-stage, loss-making growth stories and more mature platforms with operating profits, each carrying a different balance of IPO sensitivity and fundamental support.
Our screen focuses on U.S.-listed companies with market capitalizations above $500 million and a clear connection to the IPO theme, whether as a recent issuer, a public-market platform, or an infrastructure beneficiary. Stocks are ranked primarily by directness and depth of IPO exposure, with business fundamentals used as the tie-breaker and quality filter. The composite grade incorporates valuation, profitability, balance-sheet, and return measures, while the write-up also considers revenue growth and earnings surprises. This is a countdown: the best pick is reserved for #1 at the end.
What they do. The company operates iSpecimen Marketplace, a proprietary online marketplace that connects medical researchers seeking subjects, biospecimens, and related data with hospitals, laboratories, and other organizations that provide them. Its catalog includes blood products, tissue, stem cells, immune cells, and other biospecimens for biopharmaceutical, diagnostic, government, and academic customers. The marketplace model is the company’s core commercial structure, with value coming from coordinating access between research demand and specimen suppliers.
Why it fits. iSpecimen is a direct public-company exposure to an online marketplace business rather than an indirect beneficiary of new issuance. Its IPO date was June 17, 2021, and its platform connects the life-science research ecosystem across the Americas, Europe, the Middle East, Africa, and Asia Pacific. That gives the stock a clear issuer-level link to the IPO theme, although its smaller scale and weak operating record make it a speculative expression of the category.
Numbers that matter. Fundamentals are the main constraint. Revenue declined 85.2% year over year to $1,027,497, while TTM EPS was -50.48 and EBITDA was -$9,680,486. Gross margin was -29.6%, operating margin was -16.2709%, ROE was -8.9459%, and ROA was -0.9178%. The available valuation data does not provide a usable trailing or forward P/E, reinforcing that this is an execution-dependent story rather than a conventional earnings valuation.
Recent momentum. The earnings history shows a 1/4 beat rate. On August 14, 2026, reported EPS was -0.98 without a listed estimate; on November 17, 2025, EPS was -0.48 against an estimate of 0, a miss. The analyst data provides a consensus score of 5 and an average target of $3, but no buy, hold, or sell breakdown. For this ranking, iSpecimen’s direct marketplace exposure is outweighed by the scale of its losses and revenue contraction.
Market cap: $86.5M · Quality grade: B+ · Analyst consensus: not available (avg target $10.67)
What they do. FatPipe develops software-defined wide-area networking, secure access service edge, and network-monitoring solutions. Its offerings include SD-WAN, SASE, and EnterpriseView network monitoring, along with technical support, professional, cybersecurity, and training services. The company sells its software through a subscription-based model and reaches enterprises, service providers, government organizations, and middle-market customers through distributors, resellers, and other third parties.
Why it fits. FatPipe offers direct IPO exposure through a software infrastructure issuer that went public on April 8, 2025. Its SD-WAN and SASE products place it within the IPO market’s software and internet-infrastructure segment, where recurring subscription economics can make newly public companies easier to evaluate. The business is also tied to the post-listing software ecosystem: it provides the networking, security, and monitoring tools that enterprises need as cloud applications and distributed work environments expand.
Numbers that matter. FatPipe’s operating profile is stronger than its ranking suggests. Revenue grew 27.8% year over year, earnings growth was 74%, and TTM EPS was $0.39. Gross margin reached 90.7%, operating margin was 17.92%, net margin was 26.8%, ROE was 23.26%, and ROA was 6.46%. The stock carried a trailing P/E of 15.6923 and forward P/E of 11.236, while EBITDA was $3,808,564.
Recent momentum. The earnings history reports a 3/4 beat rate, including July 30 EPS of $0.09 versus an estimate of $0.07, a 28.6% surprise, and May 18 EPS of $0.3421 versus $0.10, a 242.1% surprise. There is no published analyst consensus or buy, hold, and sell count, but the average target is $10.6667. FatPipe combines a recent IPO, strong margins, and positive growth with the liquidity and valuation risks typical of a smaller public software company.
Market cap: $7.4B · Quality grade: C- · Analyst consensus: not available (avg target $29.93)
What they do. The company operates an AI-powered travel and expense platform that connects booking, policy enforcement, payments, expense reconciliation, and reporting. Navan serves finance, human-resources, travel-management, and related business functions, positioning its software as an end-to-end system for the corporate travel lifecycle. Its integration of travel, payments, and expense workflows is the central competitive proposition, with the platform designed to reduce fragmentation for business customers.
Why it fits. Navan is one of the clearest direct exposures to the renewed IPO market: the company completed its IPO on October 30, 2025, after building a large software platform in the private market. Its AI-powered travel, payments, and expense products place it squarely in the software segment that has been central to the recent issuance cycle. The stock also illustrates why IPO investing requires more than enthusiasm for a listing: a compelling platform must still demonstrate durable earnings conversion.
Numbers that matter. Revenue grew 39.9% year over year to $765,035,008, and gross margin was 72.1%, but profitability remains weak. Operating margin was -6.9%, net margin was -46.7%, ROE was -52.9%, ROA was -8.38%, and EBITDA was -$143,579,008. TTM EPS was -1.41, with next-year EPS estimated at -0.4129, while forward P/E was 138.8889. The combination of fast revenue growth and deep losses leaves valuation highly sensitive to margin improvement.
Recent momentum. Navan’s history shows a 3/5 beat rate. On June 10, EPS was -$0.06 versus an estimate of -$0.12, a 50.0% upside surprise; on March 25, EPS was $0.02 versus -$0.11, a 118.2% surprise; and on December 15, EPS was $0.14 versus -$0.17, a 182.4% surprise. Analyst consensus and the buy, hold, and sell breakdown are unavailable, while the average target is $29.9333.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Market cap: $5.9B · Quality grade: C- · Analyst consensus: not available (avg target $16.61)
What they do. Netskope provides cloud-native security, networking, and analytics through the Netskope One platform. Its products cover cloud inline security, data loss prevention, threat protection, secure web gateway, private access, software-as-a-service security posture management, enterprise browsers, firewall-as-a-service, SD-WAN, and user and entity behavior analytics. The breadth of that platform gives the company a broad enterprise cybersecurity position spanning users, data, cloud applications, private applications, and network performance.
Why it fits. Netskope is a direct IPO-market issuer, having completed its IPO on September 18, 2025. Cybersecurity has been a prominent part of the software issuance backdrop, and Netskope’s combination of zero-trust security, cloud access controls, networking, and analytics gives investors exposure to several infrastructure needs within one platform. The company therefore offers substantial thematic depth, even though its current financial profile is less mature than its enterprise product portfolio.
Numbers that matter. Revenue grew 27.8% year over year to $752,852,992, and gross margin was 69.3%. However, operating margin was -53.94%, net margin was -95.19%, ROA was -35.84%, and EBITDA was -$679,425,984. TTM EPS was -1.7, with next-year EPS estimated at -1.0918, and the available data does not provide a trailing or forward P/E. The business has meaningful growth and gross-margin support, but it must translate scale into narrower losses.
Recent momentum. Netskope has a 3/3 beat rate in the reported earnings history. On June 3, EPS was -$0.06 versus -$0.07 expected, a 14.3% upside surprise; on March 11, EPS was -$0.04 versus -$0.06, a 33.3% surprise; and on December 11, EPS was -$0.10 versus -$0.25, a 60.0% surprise. Analyst consensus is unavailable, as is the buy, hold, and sell breakdown, while the average target is $16.6111.
What they do. ServiceTitan provides an end-to-end cloud platform for contractors and other field-service businesses. The software connects advertising, scheduling, dispatching, estimates, invoicing, payments, reporting, and job management, while FieldRoutes and Aspire extend the offering into pest control and landscape-related businesses. FinTech products add payment processing and third-party financing solutions, giving the company multiple ways to participate in its customers’ operating workflows.
Why it fits. ServiceTitan completed its IPO on December 12, 2024, making it an important example of a vertical software company moving from private-market growth to public-market accountability. Its focused contractor platform gives the IPO theme a durable operating angle: the company is not merely tied to issuance activity, but is building software and financial tools into recurring business workflows. That makes it a direct issuer with a clearer path to platform economics than many newly public companies.
Numbers that matter. Revenue grew 24.6% year over year to $1,014,097,024. Gross margin was 71.1%, while operating margin was -9.58%, net margin was -13.44%, ROE was -9.04%, and ROA was -5.09%. TTM EPS was -1.52, but next-year EPS is estimated at $1.0988; forward P/E was 69.4444 and EBITDA was -$80,368,000. The valuation assumes considerable progress toward profitability, but the growth and margin profile is more developed than that of the lower-ranked loss makers.
Recent momentum. ServiceTitan has posted a 6/6 beat rate in the available history. On June 4, EPS was $0.37 versus an estimate of $0.28, a 32.1% surprise; on March 12, EPS was $0.27 versus $0.18, a 50.0% surprise; and on December 4, EPS was $0.24 versus $0.15, a 60.0% surprise. The analyst breakdown includes 2 buys and 4 holds, with no listed sells; the consensus score is 4.3333 and the average target is $110.4.
Pick #2Premium members only
Premium members see this pick's full breakdown — investment thesis, key financial metrics, recent earnings execution, and analyst consensus.
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
The screen starts with U.S.-listed companies and a market-cap threshold above $500 million, then identifies businesses with direct or meaningful exposure to the IPO ecosystem. Direct exposure includes recent issuers; indirect exposure includes brokerage, trading, software, and infrastructure platforms that can benefit from stronger issuance and public-market activity. Rankings are presented in countdown order from #7 to #1, with IPO-theme depth as the primary criterion and business fundamentals as the secondary filter. Fundamentals include revenue and earnings growth, margins, returns, valuation ratios, earnings-surprise history, analyst data, and our composite quality grade. The article is refreshed monthly, so investors should reassess valuations and operating trends when new financial data becomes available.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
